Anbio Biotechnology

NNNN ·Healthcare, Drug Manufacturers - General, Germany
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $18.9M

Liabilities Breakdown FY2024

Total Liabilities: $1.7M